BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 1360549)

  • 21. Computed tomography and 131I-MIBG scintigraphy in the diagnosis of pheochromocytoma.
    Koizumi M; Endo K; Sakahara H; Nakashima T; Nakano Y; Nakao K; Torizuka K
    Acta Radiol Diagn (Stockh); 1986; 27(3):305-9. PubMed ID: 3751679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of 131I-MIBG scintigraphy in the evaluation of suspected pheochromocytoma.
    Swensen SJ; Brown ML; Sheps SG; Sizemore GW; Gharib H; Grant CS; van Heerden JA
    Mayo Clin Proc; 1985 May; 60(5):299-304. PubMed ID: 3990377
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Total-body scintigraphy with 131I-meta-iodobenzylguanidine for detection of neuroblastoma.
    Hoefnagel CA; Voûte PA; de Kraker J; Marcuse HR
    Diagn Imaging Clin Med; 1985; 54(1):21-7. PubMed ID: 3918823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Possibility of using 131I-meta-iodobenzylguanidine in the diagnosis of neuroendocrine tumors differing from pheochromocytomas].
    Troncone L; Rufini V; Maini CL; Valenza V; Danza FM; Lasorella A
    Radiol Med; 1986 Dec; 72(12):963-8. PubMed ID: 3797720
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical usefulness of 131I-metaiodobenzylguanidine scintigraphy: experience in 6 cases].
    Ikekubo K; Habuchi Y; Jeong S; Yamaguchi H; Saiki Y; Ito H; Higa T; Hino M; Yamaoka K; Tsutsui T
    Kaku Igaku; 1986 Mar; 23(3):297-304. PubMed ID: 3735780
    [No Abstract]   [Full Text] [Related]  

  • 26. [Diagnostic localization of tumors of neuroectodermal origin using 131I-m-benzylguanidine].
    Henke E; Rönisch P; Franke WG; Krautz RM
    Radiobiol Radiother (Berl); 1988; 29(2):254-8. PubMed ID: 3399669
    [No Abstract]   [Full Text] [Related]  

  • 27. [131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
    Nakajo M; Shinohara S
    Rinsho Hoshasen; 1987 Apr; 32(4):461-70. PubMed ID: 3613180
    [No Abstract]   [Full Text] [Related]  

  • 28. Meta-iodobenzylguanidine in children.
    Gelfand MJ
    Semin Nucl Med; 1993 Jul; 23(3):231-42. PubMed ID: 8378796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The normal and abnormal distribution of the adrenomedullary imaging agent m-[I-131]iodobenzylguanidine (I-131 MIBG) in man: evaluation by scintigraphy.
    Nakajo M; Shapiro B; Copp J; Kalff V; Gross MD; Sisson JC; Beierwaltes WH
    J Nucl Med; 1983 Aug; 24(8):672-82. PubMed ID: 6135764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Results of scintigraphic studies with 131I-meta-benzylguanidine in space-occupying lesions of neuroectodermal origin].
    Mahlstedt J; Hotze A; Pichl J; Wolf F
    Nuklearmedizin; 1984 Oct; 23(5):257-64. PubMed ID: 6522275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters].
    Maurelli L; Cuocolo A; Lastoria S; Brunetti A; Maurea S; Lembo G; Klain M; Caracò C; Salvatore M
    Radiol Med; 1991 Dec; 82(6):839-43. PubMed ID: 1788441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early diagnosis of and surgical strategy for adrenal medullary disease in MEN II gene carriers.
    Jansson S; Tisell LE; Fjälling M; Lindberg S; Jacobsson L; Zachrisson BF
    Surgery; 1988 Jan; 103(1):11-8. PubMed ID: 2892276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of In-111 pentetreotide, Tc-99m (V)DMSA and I-123 mlBG scintimaging in neural crest tumors.
    Limouris GS; Giannakopoulos V; Stavraka A; Toubanakis N; Vlahos L
    Anticancer Res; 1997; 17(3B):1589-92. PubMed ID: 9179199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 131I-metaiodobenzylguanidine--a new agent for scintigraphic imaging and treatment of pheochromocytoma.
    Fischer M; Vetter W; Winterberg B; Vetter H
    Nuklearmedizin; 1984 Apr; 23(2):77-9. PubMed ID: 6473116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Localization procedures in pheochromocytoma and neuroblastoma.
    Fischer M; Galanski M; Winterberg B; Vetter H
    Cardiology; 1985; 72 Suppl 1():143-6. PubMed ID: 3902227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contribution of different scintigraphic techniques to the management of medullary thyroid carcinoma.
    Sandrock D; Blossey HC; Steinroeder M; Munz DL
    Henry Ford Hosp Med J; 1989; 37(3-4):173-4. PubMed ID: 2576957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis and treatment of neuroblastoma using 131I-meta-iodobenzylguanidine.
    Edeling CJ; Büchler Frederiksen P; Kamper J; Jeppesen P
    Nuklearmedizin; 1986 Oct; 25(5):172-5. PubMed ID: 3797256
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specificity of radioiodinated MIBG for neural crest tumors in childhood.
    Leung A; Shapiro B; Hattner R; Kim E; de Kraker J; Ghazzar N; Hartmann O; Hoefnagel CA; Jamadar DA; Kloos R; Lizotte P; Lumbroso J; Rufini V; Shulkin BL; Sisson JC; Thein A; Troncone L
    J Nucl Med; 1997 Sep; 38(9):1352-7. PubMed ID: 9293786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Applications of [131I]m-iodobenzylguanidine ([131I]MIBG).
    Beierwaltes WH
    Int J Rad Appl Instrum B; 1987; 14(3):183-9. PubMed ID: 3312118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Nuclear medicine diagnosis and treatment in pheochromocytoma and neuroblastoma].
    Fischer M
    Bildgebung; 1987-1989; 56(4):141-5. PubMed ID: 3271589
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.